Back

Pharma

2nd Annual Pre-Filled Syringes Summit

  • 26th – 27th September 2016
  • Germany flag Germany Berlin
  • Hotel Riu Plaza Berlin Martin-Luther-Straße 1, 10777

We are pleased to invite you to the ”2nd Annual Pre-Filled Syringes Summit” scheduled for the 26th - 27th of September, 2016 in Berlin, Germany.

Read more

About

This event will bring together scientific leaders from pharma & biotech, regulatory authority and academics and device manufacturers to learn and discuss the industry’s most pressing topics, benchmark best practices with their peers and ultimately learn how to overcome the problems holding back the progress.
The Summit will be focusing on the most recent trends in pharmaceutical development and manufacturing of pre-filled syringes, innovative technologies, manufacturing and regulation, embedding human factors into device design.
It is an honor and privilege to invite you to participate in this Summit.
We look forward to welcoming you at the Summit in Berlin upcoming September!

Who Should Attend

Chief Executives, Vice Presidents, Directors, Heads, Leaders, Senior Managers and Principal Scientests Specializing in:

  • PFS
  • Sterile Products
  • Combination Products
  • Medical & Connected Devices
  • Autoinjectors
  • Injectables
  • Parenterals
  • Vaccines
  • Extractables& Leachables
  • Aseptic Processing
  • Research and Development
  • Device Development & Manufacturing
  • Device Engineering & Design
  • Drug Development
  • Drug Delivery & Devices
  • Drug Packaging
  • Materials Development
  • Human Factors
  • Formulation Sciences
  • Bioformulations
  • Fill Finishing
  • Sterilization
  • Stability
  • Quality Assurance
  • Regulatory Affairs
  • Risk Management
  • Product Quality
  • CMC
  • Business Development
  • Partnerships & Alliances
  • Strategic Development
  • Sales Development
  • External Supply
  • Outsourcing

Key Practical Learning Points of the Summit

  • Current market developments and global market trends
  • New drug formulation strategies
  • Human factor and usability engineering for patient-centric
  • Device design
  • Extractable and leachable elimination
  • Primary packaging and container innovations
  • The latest technologies in materials and production process development
  • Regulatory barriers overcome, compliance and approval

Bastiaan De Leeuw, NL

Head of Business Development

Cambridge Design Partnership

Bastiaan De Leeuw has been active in the field of drug delivery for the last 20 years. He has led projects covering dry-powder formulation development, inhaler design and development, and auto-injector design and development, as well as the associated stages of clinical and regulatory evaluations. In addition, he led the initial clinical evaluation of urologic diagnostic tests at NovioGendix (now MDxHealth) and has worked at Focus Inhalation, Akela Pharma, Oval Medical, and Bespak. Bastiaan has a degree in biopharmaceutical sciences, focussing on polymeric drug delivery systems for the formulation of proteins and peptides. His research combined pharmaceutical technology and pharmacology in industry-sponsored projects. 

Mark A. Chipperfield, UK

Company Director & Principal Consultant

Corvus Device Consultancy

Mark A. Chipperfield spent 20 years working within large pharma (GSK, Sanofi Aventis, Novartis, Roche) in the field of drug delivery devices and special purpose packaging. Throughout his career, he has been heavily involved in the development of combination products in several forms: solution/suspension inhalers, multi-dose disposable and reusable dry powder inhalers, convenience kits, pen-injectors, auto-injectors, dispensers and special purpose applicators. Since 2015, he has been an independent consultant supporting pharma companies, suppliers and device innovators across the globe to develop, launch, and maintain their products.

Dana Daneshvari

Principal Scientist / Drug Product Technical Owner Technical Operations - Parenteral

Janssen Supply Chain - Schaffhausen, Switzerland

Philippe Lauwers

Business Unit Director PFS

Nipro Europe NV, Belgium

Lee Wood

CEO

MedHF

OLIVER VALET

Managing Director

rap.ID Particle Systems

Dr. Oliver K. Valet is one of the co-founders of rap.ID Particle Systems GmbH a company that develops manufactures and sells unique particle identification systems. Within the last 15 years their patented technology fuses particle isolation, imaging analysis and spectroscopic technology together to powerful investigation tools. Streamlining particle contamina­tion identification and particle characterization. Within rap.ID Dr. Valet is responsible for the product development and worldwide marketing and sales. From the FDA inspected industrial forensics laboratory work per­formed at both rap.ID sites in Berlin, Germany and Princeton, New Jersey Dr. Valet has more than a decade experience in the field of industrial and environmental chemical analysis on particles. As an active member of the Respiratory Drug Delivery, RDD, the Royal Chemical Society, Parenteral Drug Association, PDA and American Association of Pharmaceutical Sci­ence, AAPS and the Apothekerverband, APV he has published his work continuously and presented on various conferences.

Uri Baruch

Head of Drug Delivery

Cambridge Design Partnership, UK

Klaus Ullherr, DE

Senior Product Manager

Robert Bosch Packaging Technology GmbH

Klaus Ullherr, Senior Product Manager, has a degree in electrical engineering. After university he worked as a project manager in the electrical industry for several years. In March 2000, he joined Robert Bosch GmbH, Packaging Technology, Product Divi­sion Pharma Liquid. During the first two years, he was project manager responsible for handling complex customer orders. Since 2002, he is product manager for the business fields syringes and filling systems with global product responsibility. His main functions are: market analysis, initiating new product developments, business devel­opment, and expert for syringe processing. He is a member of the “PDA Interest Group pre-filled syringes” and works as an expert in the DIN/ISO group for primary packaging. Klaus is also member of ISPE and co-track-leader of the yearly ISPE Aseptic Conference. He is a well-known speaker on conferences covering trends and solutions for fill/finish equipment especially for pre-filled syringes, other pre-sterilized contain­ers, and single-use-filling-systems

DR. STEPHEN A. BARAT

Head of Pre-Clinical & Early Clinical Development

Head of Pre-Clinical & Early Clinical Development

Dr. Stephen A. Barat is the head of pre-clinical development and early clinical development for Scynexis, a biotechnology company focusing on development and commercialization of novel anti-infective treatments for life-threatening infections. He is a member of the Scynexis senior management team and has 20 years of experience in global drug devel­opment and registration from large multi-national pharmaceutical com­panies. Dr. Barat is a member of the PQRI working group for leachables and extractables for parenteral drug products and a member of the USP expert panel for biocompatibility testing. He has been an invited speaker and avid participant in various international venues on pharmaceutical development and a contributor to many continuing education courses, particularly in the area of safety assessment of impurities.

Ian Thompson, CH

Vice President Business Development, Delivery Systems med AG

Ypsomed AG

Ian Thompson has been with Ypsomed AG, formerly Disetronic AG, since 1995 in a number of roles, including key account management and business development working with pharma companies to develop and bring to market innovative self-injection systems. He studied biochemistry and biotechnology in the UK from 1979-83, working initially in commercial roles for fermentation technology. He has worked in medical device companies since moving to Switzerland in 1990. Since 2003, his main focus has been business development and new product innovation leading to the successful development and launch of a range of new pen and autoinjector custom products for Ypsomed Delivery Systems. Ypsomed Delivery Systems continues to focus on the development and manufacturing of next-generation pen, autoinjector, and wearable injector technologies.

Dr. Nicolas Brandes, GE

Director Market Development, EU/Asia

West Pharmaceutical

Dr. Nicolas Brandes is responsible for market development of West’s self-injection portfolio in Europe and Asia-Pacific. In this role, he is working closely with customers to understand their delivery device needs and to develop these opportunities together with West’s device/container R&D and commercial organisation. Before working in business development, Dr. Brandes was in charge of product management for West’s proprietary COP container portfolio made from Daikyo Crystal Zenith®, working hand in hand with the strategic partner Daikyo Seiko in Japan. Dr. Brandes received his Ph.D. in biology from the University of Wuerzburg, Germany, after performing his research studies at the University of Michigan, USA.

Wim Van Rossom

Study Director

Toxikon Europe N.V., Belgium

Thorsten Kircher

Business Development Manager

Schreiner MediPharm

Reinhard Scheller

Commercial Manager Cyclo Olefin Polymers (COP) for Europe

Zeon Europe GmbH, Germany

Bastiaan De Leeuw, NL

Head of Business Development

Cambridge Design Partnership

Mark A. Chipperfield, UK

Company Director & Principal Consultant

Corvus Device Consultancy

Dana Daneshvari

Principal Scientist / Drug Product Technical Owner Technical Operations - Parenteral

Janssen Supply Chain - Schaffhausen, Switzerland

Philippe Lauwers

Business Unit Director PFS

Nipro Europe NV, Belgium

Lee Wood

CEO

MedHF

OLIVER VALET

Managing Director

rap.ID Particle Systems

Uri Baruch

Head of Drug Delivery

Cambridge Design Partnership, UK

Klaus Ullherr, DE

Senior Product Manager

Robert Bosch Packaging Technology GmbH

DR. STEPHEN A. BARAT

Head of Pre-Clinical & Early Clinical Development

Head of Pre-Clinical & Early Clinical Development

Ian Thompson, CH

Vice President Business Development, Delivery Systems med AG

Ypsomed AG

Dr. Nicolas Brandes, GE

Director Market Development, EU/Asia

West Pharmaceutical

Wim Van Rossom

Study Director

Toxikon Europe N.V., Belgium

Thorsten Kircher

Business Development Manager

Schreiner MediPharm

Reinhard Scheller

Commercial Manager Cyclo Olefin Polymers (COP) for Europe

Zeon Europe GmbH, Germany